A Partnership of the Crohn’s & Colitis Foundation and
the American Gastroenterological Association
the American Gastroenterological Association
Join the Conversation
Menu
Congratulations to the 2023 Young Investigators Award recipients:
Madeline Alizadeh, University of Maryland School of Medicine
PREDICTORS OF DEVELOPING MULTIPLE EXTRA-INTESTINAL MANIFESTATIONS OF INFLAMMATORY BOWEL DISEASE
Suzannah Bergstein, Icahn School of Medicine at Mount Sinai
SINGLE CENTER EXPERIENCE WITH UPADACITINIB FOR REFRACTORY PEDIATRIC INFLAMMATORY BOWEL DISEASE
Sonya Dave, Medical College of Wisconsin Department of Medicine
MANAGEMENT STRATEGIES FOR OBESITY VARY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Duke Geem, Emory University School of Medicine
PRO-INFLAMMATORY SIRPα-EXPRESSING MONOCYTES AND MACROPHAGES MEDIATE ANTI-TNF REFRACTORY CROHN’S DISEASE IN CHILDREN
Daniela Guisado, Icahn School of Medicine at Mount Sinai
REPOGRAMING OF THE INTESTINAL IMMUNE CELL COMPARTMENT DEFINES THE RESPONSE TO AUTOLOGOUS STEM CELL TRANSPLANTATION IN CROHNS DISEASE
Jaslin James, Herlev Hospital
MUCOSAL EXPRESSION OF GENES PI3, ANXA1, AND VDR DESCRIMINATES CROHNS DISEASE FROM ULCERATIVE COLITIS IN INFLAMMATORY BOWEL DISEASE PATIENTS
Marianna Maspero, Cleveland Clinic
INCIDENTAL DYSPLASIA DURING TOTAL PROCTOCOLECTOMY WITH ILEOANAL POUCH: IS IT ASSOCIATED WITH WORSE OUTCOMES?
Josie McGarva, Northwestern University Feinberg School of Medicine
PRELIMINARY EVIDENCE FOR A RELATIONSHIP BETWEEN HEART RATE VARIABILITY AND FATIGUE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD)
Kara McNamara, Vanderbilt University
ACONITATE DECARBOXYLASE 1 IS A KEY REGULATOR OF COLITIS
Raaj Mehta, Massachusetts General Hospital
GUT MICROBIAL METABOLISM OF 5-ASA IS PROSPECTIVELY ASSOCIATED WITH TREATMENT FAILURE IN PATIENTS WITH IBD
The Crohn’s & Colitis Congress will award complementary registration to the 2022 meeting to up to ten young investigators and five nurses and advanced practice providers. Applications will be accepted from 9 a.m. EDT on Wednesday, Sept. 8 through 9 p.m. EDT on Wednesday, Oct. 20, 2022.
Applicants are:
Recipients will receive complementary registration to the 2021 meeting.
The deadline for young investigators and nurses to submit an application for complementary registration to the 2022 meeting has passed.
Notifications will be sent to all applicants in early December.
Applicants for the Young Investigators Abstract Award must be:
Applications may be submitted at the abstract submission site. To apply for the award, complete the “Awards” fields when submitting an abstract. Applicants are asked to verify their eligibility and also provide a brief (4000 characters maximum) personal statement.
Applicants are not required to be the submitting author of the abstract; instead, submitting authors may complete the application fields on behalf of the applicant provided that the applicant composes the personal statement.
Applications are due at the abstract submission site by 9 p.m. EDT on Wednesday, Oct. 20, 2021. Previous recipients of the award are not eligible to apply.
Contact Congress administration with any questions about applying.
Nurses and advanced practice providers may apply for complementary registration to the 2022 Crohn’s & Colitis Congress.
As part of the application, applicants are asked to submit their CV and a brief (500 words or less) personal statement.
Applications must be submitted by 9 p.m. EDT on Wednesday, Oct. 20, 2021. Previous recipients of the award are not eligible to apply.
Contact Congress administration with any questions about applying.
